Journal of Credit Risk

Systemic risk in the financial system: capital shortfalls under Brexit, the US elections and the Italian referendum

Robert Engle and Cristiano Zazzara

Recent episodes of stress in the financial system have fostered a great deal of discussion regarding new supervisory and regulatory tools for financial institutions. The recent introduction of additional capital requirements for systemically important financial institutions is one example of the concrete measures that are being taken by regulators to mitigate systemic risk. In order to assist market participants in assessing and tracking systemic risk in the financial system, the Volatility Laboratory of the NYU Stern School of Business developed a quantitative indicator, called SRISK, which estimates the expected capital shortfall faced by a firm in a potential future financial crisis. Conceptually, SRISK is similar to the stress tests that are regularly applied to financial institutions; however, it is based exclusively on publicly available information (market and accounting data) and is quick and inexpensive to compute. Those firms with a high capital shortfall in a crisis – that is, when capital is low in the financial system – are the ones with the potential to extend the crisis and impact the broader economy. We use SRISK to quantify the estimated capital shortfalls of financial institutions under three relevant stress events that occurred in 2016: Brexit, the Trump election and the Italian referendum. We refer to these events collectively as BRUMPIT. Our empirical results confirm the usefulness of SRISK in assessing the sensitivity of individual financial institutions to the BRUMPIT events. This highlights the transmission channels in terms of systemic risk.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to View our subscription options

You need to sign in to use this feature. If you don’t have a account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here